INDIANAPOLIS, Jan. 29, 2026– Eli Lilly and Company (NYSE: LLY) today announced that the U.S. Food and Drug …
Tag:
Lilly
-
-
Lifestyle & Healthslider
Lilly Brings Critical Obesity Information Closer to UAE Community Through Nationwide Awareness Campaign
by Karine Ayoubby Karine AyoubAppearing in popular healthcare facilities and community venues across the UAE, the campaign empowered …
-
Lifestyle & Healthslider
Lilly Brings Critical Obesity Information Closer to UAE Community Through Nationwide Awareness Campaign
by Karine Ayoubby Karine AyoubAppearing in popular healthcare facilities and community venues across the UAE, the campaign empowered …
-
Lifestyle & Healthslider
Lilly’s Jaypirca (pirtobrutinib) significantly improved progression-free survival, reducing the risk of progression or death by 80%, versus chemoimmunotherapy in patients with treatment-naïve CLL/SLL
by Karine Ayoubby Karine AyoubINDIANAPOLIS, December, 2025 — Eli Lilly and Company (NYSE: LLY) today announced resultsfrom the …
-
AILifestyle & HealthsliderTechnology
Reducing obesity can reshape the KSA society
by Karine Ayoubby Karine AyoubA new Study Uncovers Unprecedented Socioeconomic Benefits of Obesity Treatment in Saudi Arabia Riyadh, …
-
Lifestyle & Healthslider
Lilly’s oral GLP-1, orforglipron, is successful in third Phase 3 trial, triggering global regulatory submissions this year for the treatment of obesity
by Karine Ayoubby Karine AyoubIn ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results …